Cargando…

The role of adjuvant chemotherapy in stage I–III male breast cancer: a SEER-based analysis

BACKGROUND AND AIMS: Male breast cancer is an uncommon disease. The benefit of adjuvant chemotherapy in the treatment of male breast cancer patients has not been determined. The aim of this study was to explore the value of adjuvant chemotherapy in men with stage I–III breast cancer, and we hypothes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Wei-Ping, Gao, Hong-Fei, Ji, Fei, Zhu, Teng, Cheng, Min-Yi, Yang, Mei, Yang, Ci-Qiu, Zhang, Liu-Lu, Li, Jie-Qing, Zhang, Jun-Sheng, Wang, Kun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509722/ https://www.ncbi.nlm.nih.gov/pubmed/33014148 http://dx.doi.org/10.1177/1758835920958358

Ejemplares similares

Adjuvant chemotherapy could benefit early-stage ER/PR positive mucinous breast cancer: A SEER-based analysis
por: Gao, Hong-Fei, et al.
Publicado: (2020)

Adjuvant Chemotherapy for Stage III Colon Cancer
por: Taieb, Julien, et al.
Publicado: (2020)

Survival benefit of adjuvant chemotherapy in elderly patients with stage I triple-negative breast cancer: a cohort study based on the SEER database
por: Zhang, Yuyuan, et al.
Publicado: (2023)

Gut microbiome associated with chemotherapy-induced diarrhea from the CapeOX regimen as adjuvant chemotherapy in resected stage III colorectal cancer
por: Fei, Zuo, et al.
Publicado: (2019)

Adjuvant CDK4/6 inhibitors combined with endocrine therapy in HR-positive, HER2-negative early breast cancer: A meta-analysis of randomized clinical trials
por: Gao, Hong-Fei, et al.
Publicado: (2021)

Tumor Microenvironment Characterization in Breast Cancer Identifies Prognostic and Neoadjuvant Chemotherapy Relevant Signatures
por: Ji, Fei, et al.
Publicado: (2021)

The Role of Adjuvant Chemotherapy in Metaplastic Breast Carcinoma: A Competing Risk Analysis of the SEER Database
por: Lan, Tian, et al.
Publicado: (2021)

Survival outcomes for patients with four treatments in stages I–III esophageal squamous cell carcinoma: a SEER analysis
por: Wu, Jingyang, et al.
Publicado: (2021)

Incidence and Survival Among Young Women With Stage I–III Breast Cancer: SEER 2000–2015
por: Thomas, Alexandra, et al.
Publicado: (2019)

Treatment Patterns for Patients With Unresected Stage III NSCLC: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database
por: Shang, Shijie, et al.
Publicado: (2022)

Effect of adjuvant chemotherapy on the survival outcomes of elderly breast cancer: A retrospective cohort study based on SEER database
por: Wu, Yunhao, et al.
Publicado: (2022)

The value of adjuvant chemotherapy in stage II/III colorectal signet ring cell carcinoma
por: Zhao, Zhuang, et al.
Publicado: (2020)

Duration of FOLFOX Adjuvant Chemotherapy in High-Risk Stage II and Stage III Colon Cancer With Deficient Mismatch Repair
por: Hu, Huabin, et al.
Publicado: (2020)

Radiomics nomogram for prediction disease-free survival and adjuvant chemotherapy benefits in patients with resected stage I lung adenocarcinoma
por: Xie, Dong, et al.
Publicado: (2020)

Residual circulating tumor DNA after adjuvant chemotherapy effectively predicts recurrence of stage II‐III gastric cancer
por: Yuan, Shu‐Qiang, et al.
Publicado: (2023)

Stage III Colon Cancer: The Individualized Strategy of Adjuvant Chemotherapy for Aged Under and Over 70
por: Lu, Chieh-Sheng, et al.
Publicado: (2015)

Role of Adjuvant Chemotherapy in Stage I Pure Ovarian Immature Teratoma: A Systematic Review and Meta-Analysis
por: Li, Sijian, et al.
Publicado: (2023)

Adjuvant Chemoradiotherapy Versus Adjuvant Chemotherapy for Stage III Gastric or Gastroesophageal Junction Cancer After D2/R0 Resection
por: Shi, Jinming, et al.
Publicado: (2022)

Estimating the optimal rate of adjuvant chemotherapy utilization for stage III colon cancer
por: Karim, Safiya, et al.
Publicado: (2019)

Nutritional status predicts adjuvant chemotherapy outcomes for stage III colorectal cancer
por: Ihara, Keisuke, et al.
Publicado: (2019)

Adjuvant Chemotherapy Benefit in Elderly Stage II/III Colon Cancer Patients
por: Chen, Xin, et al.
Publicado: (2022)

Survival Outcomes of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer
por: Khalil, Lana, et al.
Publicado: (2022)

Irregular delay of adjuvant chemotherapy correlated with poor outcome in stage II-III colorectal cancer
por: Chen, Yuanyuan, et al.
Publicado: (2022)

High Expression of CUL9 Is Prognostic and Predictive for Adjuvant Chemotherapy in High-Risk Stage II and Stage III Colon Cancer
por: Zheng, Peng, et al.
Publicado: (2022)

Adjuvant chemotherapy guidance for pT1–3N0–1 breast cancer patients with HR(+), HER2(−) subtype: a cohort study based on the SEER database
por: Wen, Nan, et al.
Publicado: (2021)

Pegylated Liposomal Doxorubicin Versus Epirubicin as Adjuvant Therapy for Stage I–III Breast Cancer
por: Hu, Wenxian, et al.
Publicado: (2021)

The development and validation of a nomogram for predicting brain metastases after chemotherapy and radiotherapy in male small cell lung cancer patients with stage III
por: Yang, Baihua, et al.
Publicado: (2023)

Adjuvant chemotherapy for stage II colon cancer: who really needs it
por: Yang, Yan, et al.
Publicado: (2018)

A Population-Based Study on the Prognostic factors and Efficacy of Adjuvant Chemotherapy in the Postoperative Stage for Patients with Stage IIA Non-Small Cell Lung Cancer
por: Wang, Wei, et al.
Publicado: (2022)

Benefit of adjuvant chemoradiotherapy in patients with pathological stage III gastric cancer
por: Ma, Gui-Fen, et al.
Publicado: (2019)

Survival benefit of perioperative chemotherapy for T1–3N0M0 stage esophageal cancer: a SEER database analysis
por: Shao, Yue, et al.
Publicado: (2021)

Prognostic Value of Radiotherapy and Chemotherapy in Stage I–III Merkel Cell Carcinoma
por: Bi, Aihong, et al.
Publicado: (2022)

Prognostic evaluation of esophageal cancer patients with stages I-III
por: Qiu, Meng-jun, et al.
Publicado: (2020)

Oncologic outcomes of early adjuvant chemotherapy initiation in patients with stage III colon cancer
por: Jeong, Woon Kyung, et al.
Publicado: (2015)

Shortening adjuvant chemotherapy in stage III colon cancer: are we ready for a change?
por: Roda, Desamparados, et al.
Publicado: (2018)

Change in clinical outcomes during the transition of adjuvant chemotherapy for stage III colorectal cancer
por: Osumi, Hiroki, et al.
Publicado: (2017)

The efficacy of oxaliplatin combination adjuvant chemotherapy for elderly patients with stage III colorectal cancer
por: Hayashi, Naomi, et al.
Publicado: (2020)

Early discontinuation and dose reduction of adjuvant chemotherapy in stage III colon cancer patients
por: Boakye, Daniel, et al.
Publicado: (2021)

Association between diabetes and adjuvant chemotherapy implementation in patients with stage III colorectal cancer
por: Kanehara, Rieko, et al.
Publicado: (2022)

The effect of adjuvant chemotherapy in male breast cancer: 134 cases from a retrospective study
por: Yu, Xing-Fei, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0v11mrthgoen36v8voe40q8dkv